Breaking News

Cytiva Launches NanoAssemblr Commercial Formulation System

Single-use formulation system to enable end-to-end clinical and commercial manufacturing of lipid nanoparticle medicines.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cytiva, a global life sciences company, has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines. The NanoAssemblr is fully compliant and offers automated instrumentation using a single, scalable mixing technology for all stages of development, from research to product development to large-scale manufacturing.   The system builds on Cytiva’s NxGen technology, which produces controlled and reproducible m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters